86 related articles for article (PubMed ID: 2493720)
21. [Post-transfusional anti-HLA hyperimmunization: importance of erythropoietin].
Mourad G; Chong G; Cristol JP; Lorho R; Ramounau-Pigot A; Seignalet J
Nephrologie; 1993; 14(2):91-4. PubMed ID: 8327032
[TBL] [Abstract][Full Text] [Related]
22. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
[TBL] [Abstract][Full Text] [Related]
23. Gender disparity in kidney transplantation.
Naghibi O; Naghibi M; Nazemian F
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):545-50. PubMed ID: 18580010
[TBL] [Abstract][Full Text] [Related]
24. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
25. Effect of simvastatin in the treatment of highly sensitized dialysis patients: the pre and post-renal transplantation follow-up outcomes.
Nurhan Ozdemir F; Akcay A; Sezer S; Arat Z; Colak T; Turan M; Gulmus S; Haberal M
Transpl Immunol; 2004; 13(1):39-42. PubMed ID: 15203127
[TBL] [Abstract][Full Text] [Related]
26. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
27. HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival.
Wu HH; Tien YC; Huang CI; Chiang YJ; Chu SH; Lai PC
Transplant Proc; 2008 Sep; 40(7):2191-4. PubMed ID: 18790188
[TBL] [Abstract][Full Text] [Related]
28. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
[TBL] [Abstract][Full Text] [Related]
29. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
Seveso M; Bosio E; Ancona E; Cozzi E
Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
[TBL] [Abstract][Full Text] [Related]
30. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.
Bryan CF; Nelson PW; Shield CF; Ross G; Warady B; Murillo D; Winklhofer FT
Clin Transpl; 2004; ():127-33. PubMed ID: 16704145
[TBL] [Abstract][Full Text] [Related]
31. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ
Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284
[TBL] [Abstract][Full Text] [Related]
32. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation].
Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O
Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425
[TBL] [Abstract][Full Text] [Related]
33. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
Cecka JM; Terasaki PI
Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
[TBL] [Abstract][Full Text] [Related]
34. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
[TBL] [Abstract][Full Text] [Related]
35. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor.
Beatty PG; Mori M; Milford E
Transplantation; 1995 Oct; 60(8):778-83. PubMed ID: 7482734
[TBL] [Abstract][Full Text] [Related]
36. Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications.
Briggs D; Zehnder D; Higgins RM
Contrib Nephrol; 2009; 162():107-16. PubMed ID: 19001818
[TBL] [Abstract][Full Text] [Related]
37. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
[TBL] [Abstract][Full Text] [Related]
39. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
[No Abstract] [Full Text] [Related]
40. A model for human leukocyte antigen-matched donor-swap transplantation in India.
Basu G; Daniel D; Rajagopal A; Neelakantan N; John GT
Transplantation; 2008 Mar; 85(5):687-92. PubMed ID: 18337661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
